Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil

American Journal of Infection Control
Karina Eugênia Schimith BierLibera Maria Dalla Costa

Abstract

In the last few years, carbapenem-resistant Acinetobacter baumannii isolates (CR-AB) have been identified worldwide. The first description of OXA-23-producing A baumannii in Brazil was from the city of Curitiba in 2003. The aim of the present study was to evaluate the persistence and dissemination of the first OXA-23-producing A baumannii clone isolated from patients in Hospital de Clinicas, Curitiba, Brazil. An antimicrobial susceptibility profile of the isolates was determined by the standard agar dilution method. Molecular detection of beta-lactamase genes was done by polymerase chain reaction. The clonal relationship of the isolates was analyzed by pulsed-field gel electrophoresis (PFGE). Epidemiologic and clinical features were evaluated as well. Genotypic analysis of 172 CR-AB isolates by PFGE identified 3 distinct major PFGE clusters (A, B, and C, accounting for 36, 69, and 65 isolates, respectively). All isolates carried the bla(OXA-23)-like gene and were multidrug-resistant, but were susceptible to tigecycline and polymixin B. The mortality rate related to CR-AB infection was 45.4%, and ventilator-associated pneumonia and bloodstream infections were the most frequent clinical manifestations. The presence of 3 clones am...Continue Reading

References

Jul 11, 1998·Molecular Biotechnology·J Maule
Jul 5, 2003·Journal of Clinical Microbiology·Libera M Dalla-CostaNeil Woodford
Nov 16, 2005·The Journal of Antimicrobial Chemotherapy·R HopeD M Livermore
Mar 28, 2006·International Journal of Antimicrobial Agents·Neil WoodfordDavid M Livermore
Apr 25, 2006·FEMS Microbiology Letters·Jane F TurtonTyrone L Pitt
Jun 30, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Maria C B TognimHélio S Sader
Aug 3, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L Poirel, P Nordmann
Nov 17, 2006·Journal of Clinical Microbiology·Jubelle K ValenzuelaJon Iredell
Apr 4, 2007·Antimicrobial Agents and Chemotherapy·Maria Virginia VillegasJohn P Quinn
Jul 25, 2007·Antimicrobial Agents and Chemotherapy·Federico PerezRobert A Bonomo
Nov 17, 2007·Nature Reviews. Microbiology·Lenie DijkshoornHarald Seifert
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lisa L Maragakis, Trish M Perl
Jul 3, 2008·Current Opinion in Infectious Diseases·Timothy R Walsh
Jan 16, 2009·Journal of Clinical Microbiology·Carlos Fernández-MazarrasaLuis Martínez-Martínez
Feb 14, 2009·International Journal of Antimicrobial Agents·Karyne Rangel CarvalhoMarise Dutra Asensi

❮ Previous
Next ❯

Citations

Aug 24, 2011·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Rosângela Ferraz CeredaUNKNOWN INVITA-A-CEFTO Brazilian Study Group
Jan 23, 2013·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Natacha MartinsBeatriz Meurer Moreira
Dec 15, 2010·Antimicrobial Agents and Chemotherapy·Charline S AntonioNilton Lincopan
Mar 18, 2011·Journal of Clinical Microbiology·Alexandre R MarraUNKNOWN Brazilian SCOPE Study Group
Oct 2, 2013·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Mohan GurjarRatender Kumar Singh
Aug 28, 2014·Critical Reviews in Microbiology·Jaime A LabarcaManuel Guzmán-Blanco
Jul 25, 2013·Expert Review of Anti-infective Therapy·Juan J MayaMaria V Villegas
Mar 14, 2016·Diagnostic Microbiology and Infectious Disease·Juliana Provasi CardosoAna Cristina Gales
May 15, 2012·Burns : Journal of the International Society for Burn Injuries·Parisa AsadollahiMohammad Emaneini
May 10, 2011·International Journal of Antimicrobial Agents·Érica Lourenço FonsecaAna Carolina Paulo Vicente
Dec 16, 2011·Transplant Infectious Disease : an Official Journal of the Transplantation Society·N MartinsB M Moreira
Mar 17, 2015·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Mariana PaganoAlexandre P Zavascki
Oct 15, 2013·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Natacha MartinsBeatriz Meurer Moreira
May 15, 2013·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Flávia R BrustAlexandre P Zavascki
Nov 17, 2012·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Laís Lisboa CorrêaClaudia Rezende Vieira de Mendonça-Souza
May 30, 2016·International Journal of Antimicrobial Agents·Aba MahamatMathieu Nacher
Dec 6, 2016·Expert Review of Anti-infective Therapy·Kevin Escandón-VargasMaría Virginia Villegas
Oct 8, 2014·Antimicrobial Agents and Chemotherapy·Marcelo PillonettoMarise Dutra Asensi
Feb 24, 2018·The Pediatric Infectious Disease Journal·Mónica CerezalesLucía Gallego
May 4, 2018·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Kamile Francine SchuertzLibera Maria Dalla-Costa
Mar 18, 2020·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Gabrielle Limeira GenteluciMaria Helena Simões Villas Bôas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.